How are Norgestrel And Ethinyl Estradiol adverse event reports trending over time?
This graph shows volume of adverse events submitted to the FDA by quarter for Norgestrel And Ethinyl Estradiol, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Norgestrel And Ethinyl Estradiol is flagged as the suspect drug causing the adverse event.
What are the most common Norgestrel And Ethinyl Estradiol adverse events reported to the FDA?
Product Quality Issue | 162 (16.14%) |
Drug Ineffective | 133 (13.25%) |
Unintended Pregnancy | 128 (12.75%) |
Metrorrhagia | 62 (6.18%) |
Menorrhagia | 38 (3.78%) |
Vaginal Haemorrhage | 19 (1.89%) |
Abortion Spontaneous | 16 (1.59%) |
Vomiting | 14 (1.39%) |
Abdominal Pain Upper | 12 (1.2%) |
Abnormal Withdrawal Bleeding | 12 (1.2%) |
Insomnia | 10 (1%) |
Show More |
Share/Embed Graph Export Data
This graph shows the top adverse events submitted to the FDA for Norgestrel And Ethinyl Estradiol, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Norgestrel And Ethinyl Estradiol is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
What are the most common Norgestrel And Ethinyl Estradiol adverse events reported to the FDA?
Product Quality Issues | 163 (16.24%) |
Menstrual Cycle And Uterine Bleedin... | 156 (15.54%) |
Therapeutic And Nontherapeutic Effe... | 144 (14.34%) |
Pregnancy, Labour, Delivery And Pos... | 137 (13.65%) |
Gastrointestinal Signs | 42 (4.18%) |
Vulvovaginal Disorders | 20 (1.99%) |
Abortions And Stillbirth | 19 (1.89%) |
Embolism And Thrombosis | 16 (1.59%) |
Hepatobiliary | 15 (1.49%) |
Medication Errors | 15 (1.49%) |
Muscle | 14 (1.39%) |
Show More |
Share/Embed Graph Export Data
This graph shows the top categories of adverse events submitted to the FDA for Norgestrel And Ethinyl Estradiol, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Norgestrel And Ethinyl Estradiol is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
Why are people taking Norgestrel And Ethinyl Estradiol, according to those reporting adverse events to the FDA?
Contraception | 158 |
Off Label Use | 35 |
Menorrhagia | 14 |
Dysmenorrhoea | 13 |
Menstrual Cycle Management | 9 |
Oral Contraception | 8 |
Show More |
Label | Labeler | Effective |
---|---|---|
Cryselle | Physicians Total Care, Inc. | 20-JAN-11 |
Norgestrel/ethinyl Estradiol | Akrimax Pharmaceuticals, LLC | 29-FEB-12 |
Low-ogestrel | Watson Pharma, Inc. | 08-MAR-12 |
Ogestrel 0.5/50 | Watson Pharma, Inc. | 08-MAR-12 |
Cryselle | Barr Laboratories Inc. | 16-AUG-12 |
Elinest | Northstar Rx LLC | 01-SEP-12 |
What Norgestrel And Ethinyl Estradiol safety concerns are being reported by doctors and researchers in the medical literature?
This report contains aggregated drug side effects and adverse events for Norgestrel And Ethinyl Estradiol. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.
DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.
DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.
Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.
Share your experience with Norgestrel And Ethinyl Estradiol.